Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Advanced Malignant Neoplasm × Spironolactone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Skin Diseases 1 Rare Diseases 1 Polycystic Ovary Syndrome 1 Endocrine System Diseases 1 Advanced Malignant Neoplasm 1 Acanthosis Nigricans 1

Interventions

Sunscreening Agents 1 Spironolactone 1 Hydrocortisone 1 Doxycycline 1 Acetates 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01867294 2020-01-09

Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab

Academic and Community Cancer Research United

Phase 2 Completed

19 enrolled 9 charts

Advanced Malignant Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡